Table 2.
Characteristic | Received CPR (n=400, 57.1%) | Did not receive CPR (n=301, 42.9%) | P value |
---|---|---|---|
ICU beds | |||
<50 | 237/400 (59.3) | 197/301 (65.4) | 0.10 |
50-99 | 82/400 (20.5) | 62/301 (20.6) | 0.99 |
≥100 | 81/400 (20.3) | 42/301 (14.0) | 0.04 |
Demographics | |||
Age (years; mean (SD)) | 61 (14) | 67 (14) | <0.001 |
<45 | 52/400 (13.0) | 16/301 (5.3) | 0.001 |
45-64 | 172/400 (43.0) | 105/301 (34.9) | 0.04 |
65-79 | 142/400 (39.5) | 128/301 (42.5) | 0.06 |
≥80 | 34/400 (8.5) | 52/301 (17.3) | 0.001 |
Male sex | 266/400 (66.5) | 192/301 (63.8) | 0.46 |
Race | |||
White (non-Hispanic) | 84/400 (21.0) | 66/301 (21.9) | 0.78 |
Black (non-Hispanic) | 131/400 (32.8) | 95/301 (31.6) | 0.75 |
Hispanic | 38/400 (9.5) | 29/301 (9.6) | 0.99 |
Asian | 26/400 (6.5) | 17/301 (5.6) | 0.75 |
Unknown | 121/400 (30.3) | 94/301 (31.2) | 0.80 |
Body mass index (mean (SD))* | 32 (8) | 32 (10) | 0.92 |
<30 | 150/366 (41.0) | 133/290 (45.9) | 0.23 |
30-34 | 114/366 (31.1) | 75/290 (25.9) | 0.14 |
35-39 | 47/366 (12.8) | 29/290 (10.0) | 0.27 |
≥40 | 55/366 (15.0) | 53/290 (18.3) | 0.29 |
Coexisting conditions and risk factors† | |||
Current or former tobacco use* | 171/327 (52.3) | 142/237 (59.9) | 0.46 |
Diabetes mellitus | 201/400 (50.2) | 139/301 (46.2) | 0.29 |
Hypertension | 253/400 (63.2) | 222/301 (73.8) | 0.003 |
Coronary artery disease | 67/400 (16.8) | 46/301 (15.3) | 0.60 |
Congestive heart failure | 47/400 (11.8) | 31/301 (10.3) | 0.55 |
Chronic obstructive pulmonary disease | 31/400 (7.8) | 25/301 (8.3) | 0.79 |
Chronic or end stage kidney disease | 84/400 (21.0) | 64/301 (21.3) | 0.93 |
Active malignancy | 17/400 (4.3) | 22/301 (7.3) | 0.08 |
Laboratory values on day of ICU admission (median (IQR)) | |||
White cell count (per mm3) | 10.1 (7.0-14.3) | 10.1 (7.1-14.4) | 0.70 |
Lymphocyte count (per mm3) | 9.0 (5.0-14.0) | 7.3 (4.6-12.7) | 0.05 |
Hemoglobin (g/dL) | 12.5 (10.6-13.8) | 12.3 (10.6-13.7) | 0.57 |
Platelet count (103/μL) | 217 (168-284) | 226 (159-291) | 0.99 |
Creatinine (mg/dL) | 1.30 (0.90-2.40) | 1.51 (0.96-2.49) | 0.08 |
Albumin (g/dL) | 3.1 (2.7-3.5) | 3.1 (2.7-3.5) | 0.94 |
Aspartate aminotransferase (U/L) | 65 (41-120) | 62 (36-99) | 0.15 |
Alanine aminotransferase (U/L) | 42 (25-76) | 39 (23-59) | 0.04 |
Total bilirubin (mg/dL) | 0.6 (0.4-0.9) | 0.6 (0.4-0.9) | 0.75 |
Lactate (mmol/L) | 2.2 (1.3-3.4) | 2 (1.4-2.9) | 0.22 |
Arterial pH | 7.32 (7.22-7.44) | 7.35 (7.25-7.42) | 0.07 |
D dimer (ng/mL) | 2637 (1283-8680) | 2180 (1160-7955) | 0.44 |
C reactive protein (mg/L) | 157 (83-249) | 190.9 (110-269) | 0.04 |
Ferritin (ng/mL) | 1225 (636-2591) | 1255 (599.43-2784) | 0.84 |
mSOFA score on ICU admission | |||
Mean (SD) | 5.9 (3.3) | 6.2 (3.3) | 0.26 |
Complications‡ | |||
Invasive mechanical ventilation | 257/400 (64.3) | 234/301 (77.7) | <0.001 |
On extracorporeal membrane oxygenation | 13/400 (3.3) | 1/301 (0.3) | <0.001 |
Newly diagnosed reduced left ventricular function§ | 29/400 (7.2) | 19/301 (6.3) | 0.70 |
Receipt of at least two vasopressors | 226/400 (56.5) | 197/301 (65.4) | 0.001 |
Acute kidney injury requiring RRT | 78/400 (19.5) | 83/301 (27.6) | 0.01 |
ICU=intensive care unit; IQR=interquartile range; mSOFA=modified sequential organ Failure assessment score; RRT=renal replacement therapy; SD=standard deviation.
Denominator differs in variables for smoking and body mass index because of missing data for these specific variables (listed in supplementary appendix).
Definitions of coexisting conditions are provided in supplementary appendix.
Before cardiac arrest.
Defined as newly diagnosed left ventricular ejection fraction less than 50% on echocardiogram.